Gemphire Therapeutics Inc. (GEMP): Cormorant Asset Management Reports New Stake

Page 2 of 8 – SEC Filing

1
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Cormorant Global Healthcare Master Fund, LP
2
Check the Appropriate Box if a Member of a Group (See Instructions)
(a)            [ ]
(b)            [x]
3
SEC Use Only
4
Citizenship or Place of Organization.
Cayman Islands
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
5  Sole Voting Power
0 shares
6  Shared Voting Power
748,350 shares
Refer to Item 4 below.
7  Sole Dispositive Power
0 shares
8  Shared Dispositive Power
748,350 shares
Refer to Item 4 below.
9
Aggregate Amount Beneficially Owned by Each Reporting Person
748,350 shares
Refer to Item 4 below.
10
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)     [ ] N/A
11
Percent of Class Represented by Amount in Row (9)*
8.1%
Refer to Item 4 below.
12
Type of Reporting Person (See Instructions)
PN (Partnership)

Follow Neurobo Pharmaceuticals Inc. (NASDAQ:NRBO)